Code
01D38111
Duration
01 October 2011 → 01 October 2012
Funding
Regional and community funding: Special Research Fund
Promotor
Research disciplines
-
Natural sciences
- Genetics
-
Medical and health sciences
- Vaccinology
- Pathophysiology
- Molecular and cell biology not elsewhere classified
Keywords
kinase inhibitors
phospho-proteoom
respiratory syncytial virus
kinome
Project description
Human RSV is the most common cause of lower respiratory tract infection in infants. There is no vaccine available against this virus. The aim is to characterize host-controlled signaling kinases that are used and activated by RSV. Those kinases kan be targeted and serve as potential new anti-RSV drugs.